FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to orthopedics, and can be used for the treatment of an Osgood-Shlatter disease. To do this, in the area of the affected apophis from medial, lateral, distal and proximal sides of the tibial tuberosity, as well as from front to back in the region of maximum pain, by injection administer platelet rich autoplasma. Thus autoplasma is obtained in 10-15 minutes before the procedure and is administered in equal portions in a total dose from 2 to 3 ml.
EFFECT: method provides a low-trauma intervention, reducing the period of pain relief, acceleration of time of clinical and radiological recovery with no recurrence of the disease due to the effective stimulation of bone tissue regeneration in the knee joint as a result of revascularization, improvement of microcirculation and acceleration of metabolism of the tissues.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF THE REHABILITATION OF PATIENTS WITH CHONDROPATHY OF THE TIBIAL TUBEROSITY | 2022 |
|
RU2800245C2 |
METHOD OF SURGICAL TREATMENT OF ASEPTIC NECROSIS OF SHIN BONE TUBEROSITY (OSGOOD SCHLATTER DISEASE) | 2007 |
|
RU2338477C1 |
METHOD FOR KNEE JOINT OSTEOARTHROSIS TREATMENT | 2015 |
|
RU2620495C1 |
METHOD OF OSGOOD-SCHLATTER DISEASE MODELLING | 2007 |
|
RU2343847C1 |
METHOD FOR SURGICAL TREATMENT OF LEGG-CALVE-PERTHES DISEASE IN CHILDREN | 2020 |
|
RU2737338C1 |
METHOD FOR SURGICAL TREATMENT OF ASEPTIC NECROSIS OF TIBIAL TUBEROSITY (OSGOOD-SCHLATTER DISEASE) | 2004 |
|
RU2280417C2 |
EARLY STAGE ULTRASONIC DIAGNOSIS METHOD FOR DIAGNOSING THE CASES OF TIBIA TUBEROSITY OSTEOCHODROPATHY | 2003 |
|
RU2245678C2 |
METHOD FOR ASSESSING THE TOPICAL LOCALIZATION AND INTENSITY OF PAIN IN THE KNEE JOINT | 2017 |
|
RU2674872C1 |
METHOD OF TREATMENT CHILDREN WITH OSTEOCHONDROPATHIES | 0 |
|
SU1750700A1 |
METHOD OF TREATING OSGOOD-SCHLATTER DISEASE | 2010 |
|
RU2451494C2 |
Authors
Dates
2016-10-10—Published
2015-08-03—Filed